Boston, Sept. 23, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, the “Chromatography in Pharmaceuticals and Biotechnology: Global Markets” is projected to grow from $13.3 billion in 2025 to $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.4% from 2025 to 2030.
This report provides a comprehensive analysis of the chromatography market in the pharmaceutical and biotechnology sectors. It explores market dynamics such as drivers, challenges, and opportunities, and offers current and projected market sizes. The market is segmented by product type (instruments and reagents), with reagents further segmented by technology and subtypes of liquid chromatography. Applications covered include drug discovery, pharmaceutical analysis, and diagnostics. Additionally, the report presents a detailed regional and country-level breakdown across North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, along with profiles of leading companies, helping industry stakeholders make informed decisions on production and licensing strategies.
This report is especially relevant now due to the global rise in aging populations and chronic diseases, which is fueling demand for pharmaceuticals, particularly generics and biosimilars. As regulatory standards tighten, there is increasing focus on quality assurance and control in drug production. The report offers timely insights into advanced techniques used in drug discovery, development, and large-scale manufacturing, helping stakeholders stay ahead in a rapidly evolving industry.
The factors driving the market’s growth include:
Biopharmaceuticals: The rise in demand for biologics like monoclonal antibodies (mAbs) and vaccines is driving the need for chromatography, which is essential for purifying and analyzing these complex molecules to ensure safety and efficacy.
Integration of Good Manufacturing Practices: As pharmaceutical companies increasingly adopt GMP standards, chromatography becomes vital for quality control, helping detect impurities and validate manufacturing processes to meet regulatory requirements.
R&D for Pharmaceuticals: Increased investment in drug R&D boosts the use of chromatography for identifying active ingredients, studying drug interactions, and supporting clinical trials with analytical data.
Demand for Generics and Biosimilars: The growing market for cost-effective generics and biosimilars requires chromatography to confirm molecular similarity, purity, and bioequivalence with original branded drugs, ensuring regulatory compliance.
Request a sample copy of the global market for chromatography in pharmaceuticals and biotechnology report.
Report Synopsis
| Report Metric | Details |
| Base year considered | 2024 |